295 related articles for article (PubMed ID: 37428466)
1. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
[TBL] [Abstract][Full Text] [Related]
2. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
[TBL] [Abstract][Full Text] [Related]
3. CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer.
Chen C; Yang Y; Guo Y; He J; Chen Z; Qiu S; Zhang Y; Ding H; Pan J; Pan Y
Cell Death Dis; 2023 Apr; 14(4):271. PubMed ID: 37059712
[TBL] [Abstract][Full Text] [Related]
4. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CARM1-Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer.
Feng S; Rao Z; Zhang J; She X; Chen Y; Wan K; Li H; Zhao C; Feng Y; Wang G; Hu J; Luo X
Adv Sci (Weinh); 2023 Dec; 10(36):e2303484. PubMed ID: 37946697
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
[TBL] [Abstract][Full Text] [Related]
7. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
[TBL] [Abstract][Full Text] [Related]
10. PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
Zhang HL; Hu BX; Li ZL; Du T; Shan JL; Ye ZP; Peng XD; Li X; Huang Y; Zhu XY; Chen YH; Feng GK; Yang D; Deng R; Zhu XF
Nat Cell Biol; 2022 Jan; 24(1):88-98. PubMed ID: 35027735
[TBL] [Abstract][Full Text] [Related]
11. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
[TBL] [Abstract][Full Text] [Related]
12. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
[TBL] [Abstract][Full Text] [Related]
13. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis.
Wei Z; Hang S; Wiredu Ocansey DK; Zhang Z; Wang B; Zhang X; Mao F
J Nanobiotechnology; 2023 Jun; 21(1):188. PubMed ID: 37303049
[TBL] [Abstract][Full Text] [Related]
15. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism.
Ding K; Liu C; Li L; Yang M; Jiang N; Luo S; Sun L
Chin Med J (Engl); 2023 Nov; 136(21):2521-2537. PubMed ID: 37442770
[TBL] [Abstract][Full Text] [Related]
16. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis.
Merkel M; Goebel B; Boll M; Adhikari A; Maurer V; Steinhilber D; Culmsee C
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627584
[TBL] [Abstract][Full Text] [Related]
18. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
